Why we need a modern act to prevent harm from medications

In The News | Apr 06, 2022

Tabula Rasa’s Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy Research and Development Institute is featured in The Hill. Turgeon discusses how uncoordinated prescription regimens can lead to decreases in drug efficacy and greater risk of adverse effects, such as falls, emergency room visits, hospitalization, and even death.

Share this:

About the Author

Media Relations

Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise® Science, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care.

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4